Moxaverine

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Name
Moxaverine
Accession Number
DB12251
Type
Small Molecule
Groups
Investigational
Description

Moxaverine has been investigated for the treatment of Retina, Ocular Physiology, and Regional Blood Flow.

Structure
Thumb
Synonyms
Not Available
Product Ingredients
IngredientUNIICASInChI Key
Moxaverine Hydrochloride6R0I0E99CN1163-37-7DULZSDGCXSLVAQ-UHFFFAOYSA-N
Categories
UNII
P3P08Y1XJ4
CAS number
10539-19-2
Weight
Average: 307.393
Monoisotopic: 307.15722892
Chemical Formula
C20H21NO2
InChI Key
MYCMTMIGRXJNSO-UHFFFAOYSA-N
InChI
InChI=1S/C20H21NO2/c1-4-16-11-15-12-19(22-2)20(23-3)13-17(15)18(21-16)10-14-8-6-5-7-9-14/h5-9,11-13H,4,10H2,1-3H3
IUPAC Name
1-benzyl-3-ethyl-6,7-dimethoxyisoquinoline
SMILES
CCC1=NC(CC2=CC=CC=C2)=C2C=C(OC)C(OC)=CC2=C1

Pharmacology

Indication
Not Available
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

References

General References
Not Available
External Links
PubChem Compound
70882
PubChem Substance
347828526
ChemSpider
64045
ChEBI
135307
ChEMBL
CHEMBL2105060
Wikipedia
Moxaverine
ATC Codes
A03AD30 — Moxaverine

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
2CompletedBasic ScienceEffect of Orally Administrated Moxaverine on Ocular Blood Flow1
2CompletedTreatmentPhysiology, Ocular / Regional Blood Flow / Retina1
2CompletedTreatmentTransient ischemia attacks1
2, 3CompletedTreatmentGlaucoma / Macular Degeneration / Regional Blood Flow1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility0.00102 mg/mLALOGPS
logP5.01ALOGPS
logP4.23ChemAxon
logS-5.5ALOGPS
pKa (Strongest Basic)6.49ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count3ChemAxon
Hydrogen Donor Count0ChemAxon
Polar Surface Area31.35 Å2ChemAxon
Rotatable Bond Count5ChemAxon
Refractivity91.81 m3·mol-1ChemAxon
Polarizability35.02 Å3ChemAxon
Number of Rings3ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleYesChemAxon
MDDR-like RuleNoChemAxon
Predicted ADMET features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot Available

Taxonomy

Description
This compound belongs to the class of organic compounds known as benzylisoquinolines. These are organic compounds containing an isoquinoline to which a benzyl group is attached.
Kingdom
Organic compounds
Super Class
Organoheterocyclic compounds
Class
Isoquinolines and derivatives
Sub Class
Benzylisoquinolines
Direct Parent
Benzylisoquinolines
Alternative Parents
Anisoles / Alkyl aryl ethers / Pyridines and derivatives / Benzene and substituted derivatives / Heteroaromatic compounds / Azacyclic compounds / Organopnictogen compounds / Organonitrogen compounds / Hydrocarbon derivatives
Substituents
Benzylisoquinoline / Anisole / Alkyl aryl ether / Monocyclic benzene moiety / Pyridine / Benzenoid / Heteroaromatic compound / Ether / Azacycle / Organic oxygen compound
Molecular Framework
Aromatic heteropolycyclic compounds
External Descriptors
Not Available

Drug created on October 20, 2016 15:43 / Updated on September 02, 2019 22:02